Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF

Medical University of Graz91 enrolled

Overview

The risk of stroke is markedly elevated in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is indicated in individuals with moderate and high risk of stroke to the disadvantage of an increased burden from bleeding. Adequate knowledge of this disorder and understanding the benefits and hazards of antithrombotic treatment are essential to incorporate patient´s values and preferences in these decisions. This will further improve acceptance of recommended therapy and augment compliance with OAC. The objective of this investigation is to compare patient´s perceptions and physician´s assessments of benefits and risks of OAC.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Atrial Fibrillation Health Literacy

Interventions

QuestionnaireOTHER

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed and ECG-documented non-valvular atrial fibrillation * New indication for oral anticoagulation (OAC) * Ability of informed consent Exclusion Criteria: * Existing OAC therapy * Valvular heart disease * History of valve surgery

Locations (8)

LKH Feldbach

Feldbach, Austria

LKH Fürstenfeld

Fürstenfeld, Austria

Hospital Barmherzige Brueder Eggenberg

Graz, Austria

Hospital Barmherzige Brueder Marschallgasse

Graz, Austria

Hospital Elisabethinen

Graz, Austria

Medical University of Graz

Graz, Austria

LKH Hartberg

Hartberg, Austria

Ordination Dr. Zweiker

Straden, Austria

Outcomes

Primary Outcomes

Comparison of subjective stroke risk perception with CHA2DS2-VASc score

Time frame: Baseline

Comparison of subjective bleeding risk perception with HAS-BLED score

Time frame: Baseline

Secondary Outcomes

Relationship between accurate perception of stroke and bleeding risks and baseline parameters (highest completed level of education, subjective level of information)

Time frame: Baseline